Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AERIE PHARMACEUTICALS INC | Chief Executive Officer, Director | Common Stock | 0 | $15.25 | Nov 21, 2022 | Direct | |
AERIE PHARMACEUTICALS INC | Chief Executive Officer, Director | Stock Option (right to buy) | 0 | $9.14 | Nov 21, 2022 | Direct | |
CHIASMA, INC | CEO and President, Director | Common Stock | 0 | Aug 5, 2021 | Direct | ||
CHIASMA, INC | CEO and President, Director | Stock Option (Right to Buy) | 0 | Aug 5, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AERI | AERIE PHARMACEUTICALS INC | Nov 21, 2022 | 3 | -$7.33M | 4 | Nov 21, 2022 | Chief Executive Officer, Director |
AERI | AERIE PHARMACEUTICALS INC | Mar 18, 2022 | 1 | $0 | 4 | Mar 22, 2022 | Chief Executive Officer, Director |
AERI | AERIE PHARMACEUTICALS INC | Dec 20, 2021 | 2 | $0 | 4 | Dec 22, 2021 | Chief Executive Officer, Director |
AERI | AERIE PHARMACEUTICALS INC | Dec 20, 2021 | 0 | $0 | 3 | Dec 22, 2021 | Chief Executive Officer, Director |
CHMA | CHIASMA, INC | Aug 5, 2021 | 4 | $0 | 4 | Aug 5, 2021 | CEO and President, Director |